40108637/Experiment 4: Revision history

2 April 2025

• curprev 10:3510:35, 2 April 2025‎ Montana-D talk contribs‎ 644 bytes −67‎ No edit summary
• curprev 10:1810:18, 2 April 2025‎ Anne-mariesharp talk contribs‎ 711 bytes +1‎ No edit summary
• curprev 07:2207:22, 2 April 2025‎ KateRasheed talk contribs‎ 710 bytes +27‎ No edit summary

31 March 2025

• curprev 01:2401:24, 31 March 2025‎ Montana-D talk contribs‎ 683 bytes −25‎ No edit summary

30 March 2025

• curprev 23:3623:36, 30 March 2025‎ Montana-D talk contribs‎ 708 bytes −3‎ No edit summary
• curprev 15:5315:53, 30 March 2025‎ Montana-D talk contribs‎ 711 bytes −24‎ No edit summary
• curprev 02:5402:54, 30 March 2025‎ Montana-D talk contribs‎ 735 bytes −4‎ No edit summary
• curprev 02:5302:53, 30 March 2025‎ Montana-D talk contribs‎ 739 bytes −10‎ No edit summary

29 March 2025

• curprev 14:1714:17, 29 March 2025‎ Montana-D talk contribs‎ 749 bytes +52‎ No edit summary
• curprev 13:2313:23, 29 March 2025‎ Montana-D talk contribs‎ 697 bytes −27‎ No edit summary
• curprev 13:0113:01, 29 March 2025‎ Montana-D talk contribs‎ 724 bytes +26‎ No edit summary
• curprev 02:4402:44, 29 March 2025‎ Montana-D talk contribs‎ 698 bytes −7‎ No edit summary

28 March 2025

• curprev 01:1401:14, 28 March 2025‎ Montana-D talk contribs‎ 705 bytes +705‎ Created page with "{{Experiment |Base page=40108637 |Location of subjects=South Africa |Host species=Homo sapiens |Body site=Lateral vaginal canal |Condition=Bacterial vaginosis |Group 0 name=BV- Negative |Group 1 name=BV- Positive |Group 1 definition=These are the women in the study who, at their second visit, were diagnosed with bacterial vaginosis based on a Nugent score that met the criteria for BV-positive |Group 0 sample size=38 |Group 1 sample size=37 |Antibiotics exclusion=2 weeks..."